Related Experiment Video
Updated: Jun 15, 2025
11:13
Indirect Immunofluorescence on Frozen Sections of Mouse Mammary Gland
Published on: December 1, 2015
36.9K
Immune Cell Contribution to Mammary Gland Development.
Ramiah Vickers1, Weston Porter2
1Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine, Texas A&M University, College Station, TX, 77843, USA.
Journal of Mammary Gland Biology and Neoplasia
|August 23, 2024
Summary
Postpartum breast cancer (PPBC) arises during mammary gland involution and lactation. Sterile inflammation and innate immune pathways in mammary epithelial cells (MECs) may drive PPBC development, offering new therapeutic targets.
Area of Science:
- Reproductive biology
- Oncology
- Immunology
Background:
- Postpartum breast cancer (PPBC) accounts for nearly half of breast cancers diagnosed in women during their postpartum years.
- Mammary gland involution, characterized by a wound-healing inflammatory signature, is a key factor in PPBC initiation and progression.
- Lactation may also promote neoplastic development through sterile inflammation.
Purpose of the Study:
- To review postnatal mammary development and immune cell contributions.
- To highlight the role of mammary epithelial cells (MECs) in directing immune cell functions via cytokines.
- To explore the activation of innate immune pathways within MECs as a novel area for PPBC research.
Main Methods:
- Review of existing literature on mammary gland development, immune cell involvement, and PPBC.
- Discussion of MECs' role in immune cell function and cytokine production.
- Emphasis on the potential of studying innate immune pathways in MECs.
Main Results:
- Immune cells are integral to all stages of postnatal mammary development, with their functions influenced by MECs.
- Pregnancy and lactation involve significant MEC stress (replicative and metabolic) that can activate innate immune pathways.
- Limited research exists on immune cell contributions during pregnancy and lactation compared to other developmental stages.
Conclusions:
- Investigating innate immune pathway activation in MECs during lactation is crucial for understanding PPBC pathogenesis.
- This approach may reveal novel therapeutic biomarkers for postpartum breast cancer.
- Further research into immune cell dynamics during pregnancy and lactation is warranted.
Related Concept Videos
01:22Development of Immunocompetence
295
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
295
01:23Cells of the Adaptive Immune Response
972
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
972